申请人:INTEGRAL EARLY DISCOVERY INC
公开号:WO2020223551A1
公开(公告)日:2020-11-05
The present disclosure is directed to compounds of formulas (I) - (VII), which are useful as modulators of OTUB1. The compounds are further useful in the inhibition of OTUB1 and the treatment of diseases or disorders associated with the inhibition of OTUB1. For instance, the disclosure is concerned with compounds and compositions for inhibition of OTUB1, methods of treating diseases associated with the inhibition of OTUB1 (e.g., inflammatory diseases like irritable bowel disease and Lupus), and methods of synthesis of these compounds.
本公开涉及的是公式(I)-(VII)的化合物,它们可用作OTUB1的调节剂。这些化合物还可用于抑制OTUB1和治疗与抑制OTUB1相关的疾病或疾病。例如,本公开涉及用于抑制OTUB1的化合物和组合物,治疗与抑制OTUB1相关的疾病的方法(例如,炎症性疾病,如肠易激综合征和红斑狼疮),以及这些化合物的合成方法。